Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Neoplasms 19 Endometrial Neoplasms 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Breast Neoplasms 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Colonic Neoplasms 4 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Osteosarcoma 2 Multiple Myeloma 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Small Cell Lung Carcinoma 1

Interventions

Cisplatin 57 Pemetrexed 45 pembrolizumab 18 Nivolumab 15 Carboplatin 15 Gemcitabine 14 Cyclophosphamide 13 Radiotherapy 10 atezolizumab 8 Drug Therapy 8 Platinum 7 Ipilimumab 7 Doxorubicin 7 durvalumab 6 1,2-diaminocyclohexaneplatinum II citrate 6 tremelimumab 5 sodium thiosulfate 5 Vinorelbine 5 Radiotherapy, Intensity-Modulated 5 Interleukin-2 5 Chemotherapy, Adjuvant 5 Cerebral Decortication 5 sargramostim 4 fludarabine 4 defactinib 4 aldesleukin 4 tumor necrosis factor-alpha, CNGRC fusion protein, human 3 cediranib 3 Photochemotherapy 3 Neoadjuvant Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma, Malignant × dostarlimab × Clear all

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡